SMG 1117.329

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS

FOOD AND DRUG ADMINISTRATION

OFFICE OF THE COMMISSIONER

OFFICE OF OPERATIONS

OFFICE OF MANAGEMENT

OFFICE OF WHITE OAK SERVICES

Effective Date: 01/13/2009

1. OFFICE OF WHITE OAK SERVICES (DAMBE).

A. Provides program, technical and resources management for the Food and Drug Administration (FDA) White Oak consolidation, logistics and facilities operations and maintenance services.

B. Provides leadership and guidance to FDA Headquarters staff offices and Headquarters operating activities   for White Oak services.

C. Directs building operations functions for all FDA facilities at the White Oak Campus.

D. Provides direct interface with the General Services Administration (GSA) for White Oak services.

E. Serves as liaison with the Department of Health and Human Services (DHHS) and GSA for the efficient management and operation of facilities occupied by FDA programs at White Oak.

F. Directs and manages over a $70 million appropriation for the operation, construction, relocation, and maintenance for the White Oak Campus.

G. Provides leadership and direction to assure the efficient and effective utilization of FDA's resources dedicated to engineering design, facility improvements, and new construction of FDA facilities at White Oak.

H. Furnishes project management services including project planning, cost estimating and design, and oversight of construction until completion.

I. Ensures meaningful and continuous communication with community leaders and associations, other Federal officials, State and local governments, and business leaders and customers at White Oak.

J. Develops multiple strategies for addressing FDA's long and short-range facility plans at White Oak.

K. Develops Agency plans, policy and procedures consistent with new regulatory requirements and Agency needs for White Oak.

2. AUTHORITY AND EFFECTIVE DATE.

The functional statement for this office was approved by the Commissioner, Food and Drugs, effective January 13, 2009.

STATUS (I, R, C)	DATE APPROVED	LOCATION OF CHANGE HISTORY	CONTACT	APPROVING OFFICIAL
Initial	01/13/2009	N/a	OC/OO/OM/OMP	Commissioner of the Food and Drug Administration